WORLD HEALTH CONGRESS 2025 PRAGUE
4TH
WORLD HEALTH
CONGRESS 2025 PRAGUE
3-5 October 2025
Held under the auspices of the Capital City of Prague
českyenglishe-mailFacebookXYouTubeLinkedin
WORLD HEALTH CONGRESS 2025 PRAGUE
4TH
WORLD HEALTH CONGRESS
2025 PRAGUE
3-5 October 2025

World Health Congress 2025 Prague >> Congress program

Ing. Andrea Kestlerová, Ph.D.

Ing. Andrea Kestlerová, Ph.D. - Czech Republic

AREPIM s.r.o.
Immunologist

Abstract of the presentation

Effectiveness of Treatment in Infertile Women with Activated Cellular Immunity

Branch: Other

Clinical Sample: The study included only couples (n = 338) in which the woman tested positive for specific cellular immunity using the MIF test at the initial examination, and the male partner tested negative for antisperm autoantibodies using the MAR test. Of these women, 303 presented with infertility and 35 with recurrent miscarriage.

Methods: Specific cellular immunity was measured by the leukocyte migration inhibition test under agarose (MIF test) using antigens from the partner’s sperm, a mixed donor sperm sample, and trophoblast cells. Results were statistically evaluated using the Shapiro–Wilk test, ANOVA, Kruskal–Wallis test, and the Dwass–Steel–Critchlow–Fligner post hoc test. Statistical significance was set at p < 0.05.

Results and Discussion: All 338 women underwent standard immunological treatment, which included management of any gynecological infections, temporary avoidance of contact with ejaculate, and immunomodulatory therapy with low doses of corticosteroids. Based on treatment outcomes, patients were classified into four groups: (A) live birth within two years of the initial immunological examination; (B) live birth within 2–3 years; (C) live birth within 3–4 years; and (D) no live birth within four years. Of these, 208 patients (61.5%) conceived and delivered a healthy infant within two years of the initial examination (group A). Within four years, 264 women (78.1%; groups A + B + C) had delivered a viable infant. In group D (74 women; 21.9%), persistent MIF test positivity at follow-up appeared to be, to some extent, a predictor of reproductive failure. Overall, the immune response to treatment varied considerably between individuals, although no statistically significant differences in initial test values were found between groups.

Conclusion: The study findings suggest that the chosen diagnostic approach was appropriate and the applied treatment method highly effective, as a relatively high proportion of couples achieved reproductive success following treatment.

Please note that some of the texts also include machine-generated translations.

mapa
Institute for TCIM/CAM
Congress Organizers:
ITCIM - Institute for TCIM/CAM

Congress Co-organizers:
ANME - Association for Natural Medicine in Europe e.V.
EUAA – European Ayurveda Association
LUMEN international foundation
SANÁTOR - Professional chamber Sanátor
Foundation of Josef Zezulka
Institute for TCIM/CAM
Contact:
Soukenická 21, 110 00 Prague 1
Czech Republic

E-mail: info@itcim.org
Tel: +420 252 252 036
Whatsapp: +420 606 842 639
www.itcim.org
Links:
ABSTRACTS
REGISTRATION
VENUE
ORGANIZERS
PARTNERS
PRESIDIUM
AUSPICES
HISTORY
GDPR
The Congress organizer is not responsible for the content of individual presentations


© Tomáš Pfeiffer. All rights reserved.